Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Carel van Heerden is active.

Publication


Featured researches published by Carel van Heerden.


Human Genetics | 1996

Mapping of the variegate porphyria (VP) gene: Contradictory evidence for linkage between VP and microsatellite markers at chromosome 14q32

Louise Warnich; Peter N. Meissner; Richard J. Hift; Jan Hendrik Louw; Carel van Heerden; A.E. Retief

The gene for variegate porphyria (VP), an autosomal dominant disease with a high prevalence in South Africa, evidently due to a founder effect, was previously mapped to chromosome 14q32. In the current study this localization was evaluated by linkage and haplotype analyses using microsatellite markers spanning a region of more than 20 cM on chromosome 14q32. In many recent studies linkage disequilibrium between disease and marker loci has been utilized to map genes in founder populations, but we could not find any association between VP and the markers used in this study: Our data suggest that the allocation of VP to chromosome 14q32 may be incorrect.


PLOS ONE | 2016

The host response to a clinical MDR mycobacterial strain cultured in a detergent-free environment : a global transcriptomics approach

Gina Leisching; Ray-Dean Pietersen; Vuyiseka Mpongoshe; Carel van Heerden; Paul D. van Helden; Ian Wiid; Bienyameen Baker

During Mycobacterium tuberculosis (M.tb) infection, the initial interactions between the pathogen and the host cell determines internalization and innate immune response events. It is established that detergents such as Tween alter the mycobacterial cell wall and solubilize various lipids and proteins. The implication of this is significant since induced changes on the cell wall affect macrophage uptake and the immune response to M.tb. Importantly, during transmission between hosts, aerosolized M.tb enters the host in its native form, i.e. in a detergent-free environment, thus in vitro and in vivo studies should mimic this as closely as possible. To this end, we have optimized a procedure for growing and processing detergent-free M.tb and assessed the response of murine macrophages (BMDM) infected with multi drug-resistant M.tb (R179 Beijing 220 clinical isolate) using RNAseq. We compared the effects of the host response to M.tb cultured under standard laboratory conditions (Tween 80 containing medium -R179T), or in detergent-free medium (R179NT). RNAseq comparisons reveal 2651 differentially expressed genes in BMDMs infected with R179T M.tb vs. BMDMs infected with R179NT M.tb. A range of differentially expressed genes involved in BMDM receptor interaction with M.tb (Mrc1, Ifngr1, Tlr9, Fpr1 and Itgax) and pro-inflammatory cytokines/chemokines (Il6, Il1b, Tnf, Ccl5 and Cxcl14) were selected for analysis through qPCR. BMDMs infected with R179NT stimulate a robust inflammatory response. Interestingly, R179NT M.tb induce transcription of Fpr1, a receptor which detects bacterial formyl peptides and initiates a myriad of immune responses. Additionally we show that the host components Cxcl14, with an unknown role in M.tb infection, and Tlr9, an emerging role player, are only stimulated by infection with R179NT M.tb. Taken together, our results suggest that the host response differs significantly in response to Tween 80 cultured M.tb and should therefore not be used in infection experiments.


Journal of Clinical Microbiology | 2014

Rapid Sequencing of the Mycobacterium tuberculosis pncA Gene for Detection of Pyrazinamide Susceptibility

Elizabeth M. Streicher; Kashmeel Maharaj; Talita York; Carel van Heerden; Marinus Barnard; Andreas H. Diacon; Carl M. Mendel; Marlein E. Bosman; Juli A. Hepple; Alexander S. Pym; Robin M. Warren; Paul D. van Helden

ABSTRACT We developed a pyrazinamidase gene DNA-sequencing method to rapidly identify pyrazinamide resistance-causing mutations in GenoLyse-treated, smear-positive sputum specimens. The sensitivity and specificity were 90.9 and 100%, respectively, compared to those of MGIT drug susceptibility testing, after the exclusion of synonymous mutations and nonsynonymous mutations previously associated with susceptibility to pyrazinamide.


Experimental Dermatology | 2005

Overrepresentation of the founder PPOX gene mutation R59W in a South African patient with severe clinical manifestation of porphyria.

J. Nico P. de Villiers; Maritha J. Kotze; Carel van Heerden; Annalene Sadie; Helena F.J. Gardner; Juanita Liebenberg; René Van Zyl; Lana du Plessis; Matti Kimberg; Jorge Frank; Louise Warnich

Abstract:  A patient, who presented with abdominal pain and severe photosensitivity that resulted in scarring and mutilation of the fingers, nose and ears, was referred for biochemical assessment of porphyria and DNA screening. Although these clinical manifestations were suggestive of both acute porphyria and congenital erythropoietic porphyria, the biochemical profile was consistent with variegate porphyria (VP). Analysis of the protoporphyrinogen oxidase (PPOX) gene underlying VP resulted in the identification of the founder mutation R59W in a heterozygous state in this patient. Despite extensive mutation analysis, no other potential disease‐causing genetic alterations could be detected in the PPOX gene or the uroporphyrinogen III synthase gene. Slight overrepresentation of the mutant PPOX allele was however, observed repeatedly in DNA of the proband compared to other R59W heterozygotes, including his mother who also tested positive for mutation R59W using restriction enzyme analysis and direct DNA sequencing. Confirmation of this phenomenon by real‐time polymerase chain reaction analysis and microsatellite analysis, using highly informative markers flanking the PPOX gene, raised the possibility of partial homozygosity for VP in this patient. This study represents the first report of overrepresentation of mutation R59W in a patient with a severe form of VP. A homozygote for the R59W mutation has never been detected, and the severe clinical manifestation observed in our patient is consistent with the hypothesis that such a genotype will not be compatible with life.


Virulence | 2017

RNAseq reveals hypervirulence-specific host responses to M. tuberculosis infection.

Gina Leisching; Ray-Dean Pietersen; Carel van Heerden; Paul D. van Helden; Ian Wiid; Bienyameen Baker

ABSTRACT The distinguishing factors that characterize the host response to infection with virulent Mycobacterium tuberculosis (M.tb) are largely confounding. We present an infection study with 2 genetically closely related M.tb strains that have vastly different pathogenic characteristics. The early host response to infection with these detergent-free cultured strains was analyzed through RNAseq in an attempt to provide information on the subtleties which may ultimately contribute to the virulent phenotype. Murine bone marrow derived macrophages (BMDMs) were infected with either a hyper- (R5527) or hypovirulent (R1507) Beijing M. tuberculosis clinical isolate. RNAseq revealed 69 differentially expressed host genes in BMDMs during comparison of these 2 transcriptomes. Pathway analysis revealed activation of the stress-induced and growth inhibitory Gadd45 signaling pathway in hypervirulent infected BMDMs. Upstream regulators of interferon activation such as and IRF3 and IRF7 were predicted to be upregulated in hypovirulent-infected BMDMs. Additional analysis of the host immune response through ELISA and qPCR included the use of human THP-1 macrophages where a robust proinflammatory response was observed after infection with the hypervirulent strain. RNAseq revealed 2 early-response genes (ier3 and saa3) and 2 host-defense genes (oasl1 and slpi) that were significantly upregulated by the hypervirulent strain. The role of these genes under M.tb infection conditions are largely unknown but here we provide validation of their presence with use of qPCR and Western blot. Further analysis into their biological role during infection with virulent M.tb is required.


African Zoology | 2013

Genetic differentiation in Horus Chamberlin (Arachnida: Pseudoscorpiones: Olpiidae) as indicated by mitochondrial DNA analysis

Jacques van Heerden; Peter J. Taylor; Carel van Heerden

Horus is an olpiid pseudoscorpion of which nine species have been described from southern Africa; a tenth, debatable species was described from the Ivory Coast. The two most widely distributed species are H. granulatus and H. obscurus, the former occurring especially in the west and the other in the east, but their distributions overlap; in two instances they have been recorded from the same site. All species have a preference for rock outcrops, which are largely disjunct, and their regular prey comprises small ant species. Fieldwork over a period of 15 years indicated a very low dispersal rate; therefore one would expect localized ‘island’ populations rather than widely dispersed species. This means that the current species delimitations which lump geographically widespread populations may be incorrect. Mitochondrial DNA of specimens from each of 20 different localities across South Africa were analysed to test the hypothesis. Five of these localities did not yield results, but 14 yielded DNA from specimens which proved to belong to Horus and a fifteenth turned out to be a misidentified pseudoscorpion unrelated to Horus. The results were unequivocal: populations from each locality or group of closely-spaced localities were genetically distinct from any other one tested, and the greater the distance between localities, the greater the genetic differences (i.e. significant isolation by distance). This means that the current species delimitations for Horus are incorrect. It will require detailed micro-anatomical study to identify new characteristics on which species delimitations can be based in future.


Human Molecular Genetics | 1996

Identification of Three Mutations and Associated Haplotypes in the Protoporphyrinogen Oxidase Gene in South African Families with Variegate Porphyria

Louise Warnich; Maritha J. Kotze; Ilse M. Groenewald; Johannes Z. Groenewald; Maléne G. van Brakel; Carel van Heerden; J. Nico P. de Villiers; Wim J.M. Van de Ven; Eric F.P.M. Schoenmakers; Shigeru Taketani; A.E. Retief


South African Journal of Science | 2010

Optimisation of automated ribosomal intergenic spacer analysis for the estimation of microbial diversity in fynbos soil.

Etienne Slabbert; Carel van Heerden; Karin Jacobs


Euphytica | 2014

Detection of downy and powdery mildew resistance QTL in a ‘Regent’ × ‘RedGlobe’ population

Carel van Heerden; Phyllis Burger; Abraham Vermeulen; Renée Prins


South African Journal of Enology and Viticulture | 2018

Confirmation of the effectiveness and genetic positions of disease resistance loci in ‘Kishmish Vatkana’ (Ren1) and ‘Villard Blanc’ (Ren3 and Rpv3)

René Veikondis; Phyllis Burger; Abraham Vermeulen; Carel van Heerden; Renée Prins

Collaboration


Dive into the Carel van Heerden's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ian Wiid

Stellenbosch University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A.E. Retief

Stellenbosch University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge